Clinical Trials Law Microdosing Topical 
Canna Law Blog
NOVEMBER 27, 2021
In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction. Compass Pathways Releases Phase 2B Trial Results.
Canna Law Blog
NOVEMBER 15, 2021
Microdose hosted its annual psychedelics conference in Miami last week (appropriately titled “Wonderland”). This is a topic we have covered regularly on the Canna Law Blog, most recently by Mason Marks , here. The conference’s opening panel was on pathways to federal legalization.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 10, 2019
” Here’s some of the topics covered in their latest newsletter. Forbes reported on Hopkins researchers’ recommendation that, if psilocybin should clear Phase III clinical trials, the FDA should reclassify it from a Schedule I to a Schedule IV drug. Psychedelic Research News.
Cannabis Law Report
NOVEMBER 24, 2019
Dr. Johnson recently spoke about microdosing and its affects on creativity. Dr. Griffiths and Dr. Johnson will be speaking at Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks conference in Washington DC. Participate in Our Studies. ANOREXIA NERVOSA. ALZHEIMER’S DISEASE.
Cannabis Law Report
JUNE 4, 2021
Legislative initiatives (introduction and support of changes of laws). Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Mr Psychedelic Law & Iter Investments.
Expert insights. Personalized for you.
88 
Let's personalize your content